A global phase IV, double-blind, placebo-controlled, randomized trial to evaluate the effectiveness of detrusitol [tolterodine] sr 4mg on patient's perception of bladder condition (PPBC)

Trial Profile

A global phase IV, double-blind, placebo-controlled, randomized trial to evaluate the effectiveness of detrusitol [tolterodine] sr 4mg on patient's perception of bladder condition (PPBC)

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Nov 2012

At a glance

  • Drugs Tolterodine (Primary)
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Nov 2012 Planned number of patients changed from 600 to 730 as reported by European Clinical Trials Database record.
    • 01 Dec 2008 Updated trial centres.
    • 30 Aug 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top